Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label single-arm study of HS-10374 in adults with moderate-to-severe plaque psoriasis
CTR20251164Phase 3Completed
- Sponsor
- Changzhou Hengbang Pharmaceutical
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HS-10374 in plaque psoriasis, psoriasis, sponsored by Changzhou Hengbang Pharmaceutical. Started Apr 2025; status: completed.
02
Drugs
HS-10374
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on CTR20251164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251164.